阳光诺和荣获第二十七届上市公司“新质企业金牛奖”

Core Insights - The 2025 High-Quality Development Forum and the 27th Golden Bull Award Ceremony were held in Nantong, Jiangsu, with the theme "Moving Towards New Heights, Achieving Practical Results, and Enlightening the Future" [1] - Sunshine Nuohuo won the "New Quality Enterprise Golden Bull Award" due to its strong development momentum and stable operating performance [1][5] Group 1: Award Overview - The Golden Bull Award, established in 1999 by China Securities Journal, aims to create a credible and authoritative platform for showcasing listed companies in the capital market [4] - The award recognizes companies with standardized governance, performance growth, and positive shareholder and societal returns [4] Group 2: Award Categories and Winners - This year's Golden Bull Award featured nine categories, including "Most Investment Value Award" and "New Quality Enterprise Golden Bull Award," with 55 companies receiving the latter [5] - Sunshine Nuohuo is a professional CRO providing comprehensive drug development services for domestic pharmaceutical companies and research institutions [5] Group 3: Company Performance - For the first three quarters of 2025, Sunshine Nuohuo reported revenue of 856 million yuan and a net profit attributable to shareholders of 163 million yuan [5] - The net cash flow from operating activities reached 148 million yuan, reflecting a year-on-year increase of 36.63% [5]